Johnson & Johnson sued the Biden administration over Medicare’s new powers to slash drug prices, making it the third pharmaceutical company to challenge the controversial provision of the Inflation Reduction Act.

  • eric@lemmy.world
    link
    fedilink
    English
    arrow-up
    15
    arrow-down
    2
    ·
    1 year ago

    I bet it will cause neo-cons to flock to J&J products to help support the poor wittle multinational corporation.